[i] Choe H.M,Mitovich S,Dubay D, et al.
Proactive Case Management of High-risk Patients With
Type 2 Diabetes Mellitus by a Clinical Pharmacist: A Randomized
Controlled Trial. Am J Manag Care. 2005;11:253-260.
[ii] Rothman RL, Malone R, Bryant B, et
al. A randomized trial of a primary care-based disease
management program to improve cardiovascular risk factors and
glycated hemoglobin levels in patients with diabetes. American
Journal of Medicine 2005. 118: p. 276-284.
[iii] Leal S, Glover JJ, Herrier RN,
Felix A: Improving quality of care in diabetes through a
comprehensive pharmacist-based disease management program.
Diabetes Care 2004, 27(12):2983-2984.
[v] Perez-Cuevas R, Reyes-Morales H,
Flores-Hernandez S, Wacher-Rodarte N. [Effect of a clinical
practice guideline for the management of diabetes type 2]. Rev
Med Inst Mex Seguro Soc 2007;45:353-60.
[vi] Peters-Klimm F, Muller-Tasch T,
Remppis A, Szecsenyi J, Schellberg D. Improved guideline adherence
to pharmacotherapy of chronic systolic heart failure in general
practice--results from a cluster-randomized controlled trial of
implementation of a clinical practice guideline. J Eval Clin
Pract 2008;14:823-9.
[vii] Keris V, Lavendelis E, Macane I.
Association between implementation of clinical practice guidelines
and outcome for traumatic brain injury. World J Surg
2007;31:1352-5.
[viii] Horning KK, Hoehns JD, Doucette
WR. Adherence to clinical practice guidelines for 7 chronic
conditions in long-term-care patients who received pharmacist
disease management services versus traditional drug regimen review.
J Manag Care Pharm 2007;13:28-36.